Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of febuxostat 80 mg film-coated tablets in healthy Thai volunteers under fasting conditions
TCTR20210809006Phase 1Completed
- Sponsor
- Unison Laboratories
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of febuxostat (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 1 more. Started Nov 2021; status: completed.
02
Drugs
febuxostat
Beyond the preview
Go deeper on TCTR20210809006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210809006.